TEST BANK For Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Nader Rifai, Verified Chapters 1 - 49, Complete Newest Version

Test bank for Tietz Fundamentals of Clinical Chemistry
we we we we we we we




we and Molecular Diagnostics,
we we we




8th Edition by Nader Rifai, PhD
we we we we we we




Chapters 1 - 49 we we we we

,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
we we we we we we we we
we
we we




Table of contents:
we we




I. Principles Of Laboratory Medicine
we we we we




Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
we we we we we we we we




Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
we we we we we we we we we we we




Chapter 3. Clinical Evaluation of Methods
we we we we we




Chapter 4. Evidence-Based Laboratory Medicine
we we we we




Chapter 5. Establishment and Use of Reference Values
we we we we we we we




Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
we we we we we we we we




Chapter 7. Quality Management
we we we




II. Analytical Techniques And Instrumentation
we we we we




Chapter 8. Principles of Basic Techniques and Laboratory Safety
we we we we we we we we




Chapter 9. Optical Techniques
we we we




Chapter 10. Electrochemistry and Chemical Sensors
we we we we we




Chapter 11. Electrophoresis
we we




Chapter 12. Chromatography
we we




Chapter 13. Mass Spectrometry
we we we




Chapter 14. Enzyme and Rate Analyses
we we we we we




Chapter 15. Immunochemical Techniques
we we we




Chapter 16 Automation we we




Chapter 17. Point-of-Care Instrumentation
we we we




III. Analytes
w e




Chapter 18. Amino Acids, Peptides, and Proteins
we we we we we we




Chapter 19. Serum Enzymes
we we we




Chapter 20. Tumor Markers and Cancer Genes
we we we we we we




Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
we we we we we we we we we we we




Chapter 22. Carbohydrates
we we




Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
we we we we we we we we we




Chapter 24. Electrolytes and Blood Gases
we we we we we




Chapter 25. Hormones we we




Chapter 26. Catecholamines and Serotonin
we w e we we




Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
we w e we we we we




Chapter 28. Hemoglobin, Iron, and Bilirubin
we we we we we




Chapter 29. Porphyrins and Porphyrias
we we we we




Chapter 30. Therapeutic Drugs and Their Management
we we we we we we




Chapter 31. Clinical Toxicology
we we we




Chapter 32. Toxic Metals
we w e we




IV. Pathophysiology
w e




Chapter 33. Diabetes we we

,Chapter 34. Cardiovascular Disease
we w e we




Chapter 35. Kidney Disease
we we we




Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
we w e we we we we we we we we




Chapter 37. Liver Disease
we we we we




Chapter 38. Gastrointestinal and Pancreatic Diseases
we w e we we we




Chapter 39. Disorders of Bone and Mineral Metabolism
we we we we we we we we




Chapter 40. Disorders of the Pituitary Gland
we we we we we we we




Chapter 41. Disorders of the Adrenal Cortex
we w e we we we we




Chapter 42. Thyroid Disorders
we w e we




Chapter 43. Reproduction-Related Disorders
we w e we




Chapter 44. Pregnancy and Prenatal Testing
we we we we we we




Chapter 45. Newborn Screening and Inborn Errors of Metabolism
we w e we we we we we we




Chapter 46. Pharmacogenetics
we we




V. Molecular Diagnostics
w e we




Chapter 47. Principles of Molecular Biology
we we we we we




Chapter 48. Nucleic Acid Techniques and Applications
we we we we we we




Chapter 49. Genomes and Nucleic Acid Alterations
we we we we we we

, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
we we we we we we we we



TestBank
we ew




MULTIPLE CHOICE we




1. An individual working in a clinical chemistry laboratory is married to a sales
we we we we we we we we we we we we



representative who works for a company that sells chemistry laboratory supplies. When
we we we we we we we we we we we we



the laboratory manager requests a list of needed supplies, cost of supplies, and vendors,
we we we we we we we we we we we we we we



this individual onlyrecommends the spouse’s company as the vendor. This is considered
we we we ew we we we we we we we we we



to be a(n):
we we we



a. accounting issue. we



b. possible conflict of interest. we we we



c. maintenance of confidentiality issue. we we we



d. problem with resource allocation. we we we




ANS: B w e



Concern has been raised over the interrelationships between practitioners in the medical
we we we we we we we we we we we



fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical
we ew we we we we we we we we we we



profession.
we



Similarly, relationships have been scrutinized between clinical laboratorians and
we we we we we we we we



manufacturers and providers of diagnostic equipment and supplies. These concerns led the
we we we we we we we we we we we we



National Institutes of Health (NIH) in 1995 to require official institutional review of
we we we we we we we we we we we we we



financial disclosure by researchers and management of situations in which disclosure
we we we we we we we we we we we



indicates potentialconflicts of interest.
we we ew we we




DIF: 1 REF: we we we Page 4-5 we OBJ: 6 | 7 w e we we




2. A patient visits her physician stating that her prescribed painkiller is not working to
we we we we we we we we we we we we we



reduce the pain following her recent surgery. A friend of the patient claims that the
we we we we we we we we we we we we we we we



same painkiller“worked wonders” to reduce her pain after the same surgery. The
we we ew we we we we we we we we we we



physician states that the difference in the effect of the drug might be caused by
we we , we we we we we we we we we we we we we



which is studied in pharmacogenetics.
we we we we we



a. epidemiology
b. an inherited disease we we



c. a conflict of interest
we we we



d. a genetic variation in drug-metabolizing enzymes
we we we we we




ANS: D w e



Pharmacogenetics is the study of the genetic variation of drug metabolism we we we we we we we we we we



betweenindividuals.
we ew




DIF: 1 REF: we we w e Page 3 we OBJ: 1 w e




3. John works in a molecular diagnostics laboratory and receives a blood sample that has
we we we we we we we we we we we we we



the name of a close friend printed on the bar-coded label. The genetic test that is
we we we we we we we we we we we we we we we we



ordered on thefriend’s sample would provide diagnostic information about a disorder
we we we ew we we we we we we we we



that has a poor prognosis, and the test is usually performed by John. He asks a fellow
we we we we we we we we we we we we we we we we we



employee to analyzethe sample for him and not divulge the results. This ethical issue
we we we ew we we we we we we we we we we we



concerns:
we



a. confidentiality of patient genetic and medical information. we we we we we we



b. a conflict of interest.
we we we



c. resource allocation. we



d. diagnostic accuracy. we